Everything below concerns AOD-9604. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-04-19. Numbers and descriptions here follow the published literature rather than marketing material.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Peptide fragment | Corresponds to hGH residues 176-191 |
| Common synonyms | AOD9604, hGH 176-191 | Also written as AOD-9604 |
| Typical form | Lyophilized powder | Often supplied in sealed vials |
| Solubility | Water-soluble | Dissolves in aqueous buffers |
| Regulatory status | Not approved as drug | Banned in sport; varies by country |
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
== The Monolith Summer School == Since 2004, BIA Separations has organized and hosted the Monolith Summer School and Symposium (MSS) which takes place every 2 years. MSS was established as there were no dedicated conferences to this technology and to bring together the top international scientists and researchers in the area of monolith chromatography to share their experiences and innovative applications.
=== Acetals and hemiacetals === Hemiacetals and acetals are essentially tetrahedral intermediates. They form when nucleophiles add to a carbonyl group, but unlike tetrahedral intermediates they can be very stable and used as protective groups in synthetic chemistry. A very well known reaction occurs when acetaldehyde is dissolved in methanol, producing a hemiacetal. Most hemiacetals are unstable with respect to their parent aldehydes and alcohols. For example, the equilibrium constant for reaction of acetaldehyde with simple alcohols is about 0.5, where the equilibrium constant is defined as K = [hemiacetal]/[aldehyde][alcohol]. Hemiacetals of ketones (sometimes called hemiketals) are even less stable than those of aldehydes. However, cyclic hemiacetals and hemiacetals bearing electron withdrawing groups are stable. Electron-withdrawing groups attached to the carbonyl atom shift the equilibrium constant toward the hemiacetal. They increase the polarization of the carbonyl group, which already has a positively polarized carbonyl carbon, and make it even more prone to attack by a nucleophile. The chart below shows the extent of hydration of some carbonyl compounds. Hexafluoroacetone is probably the most hydrated carbonyl compound possible. Formaldehyde reacts with water so readily because its substituents are very small- a purely steric effect.
is equal to zero, which means that for an incompressible fluid the flow velocity field is a solenoidal vector field or a divergence-free vector field. Note that this relationship can be expanded upon due to its uniqueness with the vector Laplace operator
Sources: en.wikipedia.org
=== Kevin Rawle === Kevin Rawle (Pip Torrens) is the brash, conniving editor-in-chief of The Patriot, a right-leaning tabloid owned by Lord Norton. Yasmin enlists Kevin to circulate a fictitious claim that the Labour government suppressed an internal memo voicing concerns about Tender's fraudulent practices, thereby pinning the company's failure on the government and protecting her from legal and reputational fallout. She, Kevin and Norton attempt to persuade Labour MP Jennifer Bevan to be their source, but she refuses on principle. Yasmin later has Harper pass on the claim to FinDigest editor Edward Burgess, who publishes it; The Patriot then amplifies the claim, leading to the resignation of business secretary Lisa Dearn and opening Tender to fraud investigations and a new audit.
== Advertising == The Guinness harp motif is modelled on the Trinity College harp. It was adopted in 1862 by the incumbent proprietor, Benjamin Lee Guinness. Harps have been a symbol of Ireland at least since the reign of Henry VIII. Guinness registered their harp as a trademark shortly after the passing of the Trade Marks Registration Act 1875. It faces right instead of left, and so can be distinguished from the Irish coat of arms. Since the 1930s, in the face of falling sales, Guinness has had prominent marketing campaigns, from television advertisements to beer mats and posters. Before then, Guinness had almost no advertising, instead allowing word of mouth to sell the product.
In physics, a vapor (American English) or vapour (Commonwealth English; see spelling differences) is a substance in the gas phase at a temperature lower than its critical temperature, which means that the vapor can be condensed to a liquid by increasing the pressure on it without reducing the temperature of the vapor. A vapor is different from an aerosol. An aerosol is a suspension of tiny particles of liquid, solid, or both within a gas. For example, water has a critical temperature of 647 K (374 °C; 705 °F), which is the highest temperature at which liquid water can exist at any pressure. In the atmosphere at ordinary temperatures gaseous water (known as water vapor) will condense into a liquid if its partial pressure is increased sufficiently. A vapor may coexist with a liquid (or a solid). When this is true, the two phases will be in equilibrium, and the gas-partial pressure will be equal to the equilibrium vapor pressure of the liquid (or solid).
ALK-positive ALCL occurs mostly but not exclusively in children and young adults and is slightly more common in males. Most individuals present with stage III or IV (i.e. advanced) disease. They evidence systemic symptoms including B symptoms such as fever, night sweats, and weight loss in 75% of cases; lymph node enlargement (90%) including those in the mediastinum (36%); and lymphomatous lesions in the skin (26%), bone (14%), soft tissues (15%), lung (12%), and/or liver (8%). Tumor cells are found in the bone marrow in up to 40% of the cases when immunohistochemical analysis is performed. Involvement of the central nervous system or a leukemia-like circulation of malignant cells in the blood occurs only very rarely. Most patients, including up to 90% of young children and adolescents, have circulating autoantibodies directed against the ALK fusion protein expressed by their tumor cells.
Sources: en.wikipedia.org
== Side effects == The most common side effect in all insulin analogues is low blood sugar, while in more serious cases, side effects may include low blood potassium. Insulin allergies are also a concern, although they are not prevalent, affecting only about 2% of people in some form. Insulin analogues are generally considered safe during pregnancy, and many are used in the treatment of gestational diabetes.
=== September 2008 === The European Parliament adopted a resolution on 3 September 2008, which noted that the large-scale war was preceded by Russian assistance to the separatists, as well as South Ossetian attacks against the Georgians. It also noted that the eventual Russian large-scale invasion followed "a long-term military build-up". In September 2008, Secretary of the National Security Council of Georgia Alexander Lomaia was asked by journalist why the Georgian authorities fell into Russian trap despite warnings from the United States, Lomaia suggested that Georgia had to avert the scenario of 1921. When again asked whether Georgia fell into a trap, he said that the Georgian government still regarded the situation in the same way as back then during the beginning of hostilities. In early September 2008, former Russian intelligence officer Boris Volodarsky said in an interview that he had information that Russian tanks had passed the Roki pass 20 minutes before the Georgian counterattack on Tskhinvali and Russia shelled Tskhinvali with the BM-21 Grads. In September 2008, economist Yegor Gaidar said that accomplished financial experts knew before the war that the war in the Caucasus was imminent after Kosovo and calculated how the war would impact the economics of Russia. On 9 September, Eric S.
=== Bone repair === Bone has a unique and well-documented natural healing process that normally is sufficient to repair fractures and other common injuries. Misaligned breaks due to severe trauma, as well as treatments like tumor resections of bone cancer, are prone to improper healing if left to the natural process alone. Scaffolds composed of natural and artificial components are seeded with mesenchymal stem cells and placed in the defect. Within four weeks of placing the scaffold, newly formed bone begins to integrate with the old bone and within 32 weeks, full union is achieved. Further studies are necessary to fully characterize the use of cell-based therapeutics for treatment of bone fractures. Stem cells have been used to treat degenerative bone diseases in dogs. The normally recommended treatment for dogs that have Legg–Calve–Perthes disease is to remove the head of the femur after the degeneration has progressed. Recently, mesenchymal stem cells have been injected directly in to the head of the femur, with success not only in bone regeneration, but also in pain reduction.
Mechanical or elastic gauges depend on a Bourdon tube, diaphragm, or capsule, usually made of metal, which will change shape in response to the pressure of the region in question. A variation on this idea is the capacitance manometer, in which the diaphragm makes up a part of a capacitor. A change in pressure leads to the flexure of the diaphragm, which results in a change in capacitance. These gauges are effective from 103 torr to 10−4 torr, and beyond. Thermal conductivity gauges rely on the fact that the ability of a gas to conduct heat decreases with pressure. In this type of gauge, a wire filament is heated by running current through it. A thermocouple or Resistance Temperature Detector (RTD) can then be used to measure the temperature of the filament. This temperature is dependent on the rate at which the filament loses heat to the surrounding gas, and therefore on the thermal conductivity. A common variant is the Pirani gauge which uses a single platinum filament as both the heated element and RTD. These gauges are accurate from 10 torr to 10−3 torr, but they are sensitive to the chemical composition of the gases being measured. Ionization gauges are used in ultrahigh vacuum. They come in two types: hot cathode and cold cathode. In the hot cathode version an electrically heated filament produces an electron beam. The electrons travel through the gauge and ionize gas molecules around them. The resulting ions are collected at a negative electrode. The current depends on the number of ions, which depends on the pressure in the gauge.
5 December Junior doctors in England will stage further strike action after rejecting the latest pay offer, the British Medical Association confirms, with a three-day strike scheduled to begin on 20 December and a six-day strike scheduled to begin on 3 January 2024. The Scottish Prison Service issues new guidelines on transgender prisoners. Trans women who have hurt or threatened women or girls will not be sent to a female prison unless there are "exceptional" circumstances. Jesse Darling is announced as the winner of the 2023 Turner Prize. 6 December Boris Johnson, who served as prime minister from 2019 to 2022, appears before the COVID-19 inquiry and is questioned by Hugo Keith, counsel to the inquiry. He apologises for the "pain and the loss and the suffering" people experienced during the pandemic. His comments are interrupted by protesters, who are ordered to leave the inquiry room. Robert Jenrick resigns as immigration minister after the government publishes an emergency Rwanda bill. 7 December Figures released by Halifax Bank indicate house prices in the UK rose by 0.5% in November 2023. Culture Secretary Lucy Frazer confirms the TV licence fee will increase by £10.50 from £159 to £169.50 from 1 April 2024. Serial killer Steve Wright is arrested for the September 1999 murder of Victoria Hall. 8 December A letter to MPs from Sir Matthew Rycroft, the Permanent Under-Secretary of State of the Home Office, says that £240m has been paid so far to Rwanda for the Rwanda asylum plan, with a further £50m to be paid in 2024.
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.
No, it is a small fragment of the full growth hormone protein. It does not appear to stimulate growth or increase growth hormone levels in the same way. Its actions are thought to be more limited to metabolic pathways.
Regulatory status varies. It is not approved for medical use in the United States or many other countries. It is banned in sport by WADA, and its sale as a supplement or research chemical may be subject to legal restrictions.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.